Found 541593 clinical trials
Sort by:
Does Vitamin C Improve Postoperative Healing
Not Applicable
Completed
- Conditions
- Impacted Mandibular Third Molar
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Hacettepe University
- Target Recruit Count
- 56
- Registration Number
- NCT07012564
- Locations
- 🇹🇷
Hacettepe University Faculty of Dentistry, Ankara, Turkey
Efficacy of Phycocyanin and Palmitoylethanolamide for the Treatment of Chronic Prostatitis Symptoms
Phase 4
Completed
- Conditions
- Chronic Prostatitis (CP)Chronic Prostatitis With Chronic Pelvic Pain SyndromeChronic Prostatitis/ Pelvic Pain Syndrome
- Interventions
- Drug: FICOXPEA® is an oral combination of Phycocyanin, Palmitoylethanolamide and selenium
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Clinica Urologica Molinette - Città della Saliute e della Scienza
- Target Recruit Count
- 48
- Registration Number
- NCT07013890
- Locations
- 🇮🇹
Dipartimento di Chirurgia Università di Catania, Catania, Italy
🇮🇹Molinette Hospital, Torino, Italy
QOL and Mental Health Using APD With Remote Monitoring System
Not Applicable
- Conditions
- Quality of LifeMental Health Wellness 1
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Wonju Severance Christian Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT07012499
- Locations
- 🇰🇷
Wonju Severance Christian Hospital, Wŏnju, Kangwondo, Korea, Republic of
SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
Recruiting
- Conditions
- Inflammatory Bowel Disease (IBD)
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT07011979
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas
Phase 2
Not yet recruiting
- Conditions
- Sarcoma
- Interventions
- Drug: ABSK043 single agent
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 20
- Registration Number
- NCT07014137
- Locations
- 🇨🇦
UHN- Princess Margaret Cancer Center, Toronto, Ontario, Canada
PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy
Phase 2
Not yet recruiting
- Conditions
- NSCLC (Advanced Non-small Cell Lung Cancer)Resistance to Immunotherapy
- Interventions
- Drug: Sintilimab combined with Bevacizumab and tafolecimab
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Anhui Provincial Cancer Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT07014215
The Effect of Using Virtual Reality in Subcutaneous Injection Education on the Knowledge and Skills of Nursing Students
Not Applicable
Recruiting
- Conditions
- Nursing EducationNursing Education ResearchVirtual GogglesVirtual Reality
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Baskent University
- Target Recruit Count
- 70
- Registration Number
- NCT07012187
- Locations
- 🇹🇷
Baskent University, Ankara, Turkey
Transfusion Reduction in High-Bleeding-Risk Cardiac Surgery With Desmopressin
Phase 3
Not yet recruiting
- Conditions
- Adult Patients Undergoing Cardiac SurgeryHigh Bleeding RisksPlanned Elective Cardiac Surgery Using CPB
- Interventions
- Drug: DesmopresinDrug: Placebo
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Imam Abdulrahman Bin Faisal University
- Target Recruit Count
- 112
- Registration Number
- NCT07012837
- Locations
- 🇸🇦
Imam Abdulrahamn Bin Faisal University (Former, Dammam University), Dammam, Eastern, Saudi Arabia
Prospective Study of Bone Augmentation With Lateral Sinus Lift and Osseointegration of Dental Implants
Not Applicable
Not yet recruiting
- Conditions
- Atrophic MaxillaPartial Edentulism
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Maria H. Pham
- Target Recruit Count
- 20
- Registration Number
- NCT07014085
Does Hr-HPV Status Influence the 2011 IFCPC Nomenclature and Swede Score's Capacity to Diagnose Precancerous Lesions?
Completed
- Conditions
- ColposcopyHPVHSIL
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Necmettin Erbakan University
- Target Recruit Count
- 95
- Registration Number
- NCT07012356
- Locations
- 🇹🇷
Necmettin Erbakan University, Konya, Meram, Turkey